Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation to Evaluate the Haemonetics LeukoSep Leukocyte Reduction Filtration System for Whole Blood With CPD Anticoagulant and SOLX Additive - Pivotal Trial

NCT02145507 is registered in ClinicalTrials.gov with Haemonetics Corporation as lead sponsor.

NCT NCT02145507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation to Evaluate the Haemonetics LeukoSep Leukocyte Reduction Filtration System for Whole Blood With CPD Anticoagulant and SOLX Additive - Pivotal Trial
Lead sponsor
Haemonetics Corporation
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
January 31, 2015
Enrollment
170 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood donors